Cardiac Toxicity of Alectinib in Patients With ALK+ Lung Cancer: Outcomes of Cardio-Oncology Follow-Up

por Pruis, Melinda A., Veerman, G.D. Marijn, Hassing, H. Carlijne, Lanser, Daan A.C., Paats, Marthe S., van Schaik, Ron H.N., Mathijssen, Ron H.J., Manintveld, Olivier, Dingemans, Anne-Marie C.
Publicado 2023

Improving the tolerability of osimertinib by identifying its toxic limit

por Agema, Bram C., Veerman, G. D. Marijn, Steendam, Christi M. J., Lanser, Daan A. C., Preijers, Tim, van der Leest, Cor, Koch, Birgit C. P., Dingemans, Anne-Marie C., Mathijssen, Ron H. J., Koolen, Stijn L. W.
Publicado 2022